242 related articles for article (PubMed ID: 11591435)
21. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
Singh I; Pahan K; Dhaunsi GS; Lazo O; Ozand P
J Biol Chem; 1993 May; 268(14):9972-9. PubMed ID: 8486724
[TBL] [Abstract][Full Text] [Related]
22. Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals.
Mannaerts GP; Van Veldhoven PP; Casteels M
Cell Biochem Biophys; 2000; 32 Spring():73-87. PubMed ID: 11330072
[TBL] [Abstract][Full Text] [Related]
23. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
24. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
Wierzbicki AS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
[TBL] [Abstract][Full Text] [Related]
25. Phytanic acid alpha-oxidation: identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its localisation in peroxisomes.
Jansen GA; Verhoeven NM; Denis S; Romeijn G; Jakobs C; ten Brink HJ; Wanders RJ
Biochim Biophys Acta; 1999 Sep; 1440(2-3):176-82. PubMed ID: 10521701
[TBL] [Abstract][Full Text] [Related]
26. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
27. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
Mihalik SJ; Rainville AM; Watkins PA
Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
[TBL] [Abstract][Full Text] [Related]
28. Biochemical markers predicting survival in peroxisome biogenesis disorders.
Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
[TBL] [Abstract][Full Text] [Related]
29. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Zomer AW; van Der Burg B; Jansen GA; Wanders RJ; Poll-The BT; van Der Saag PT
J Lipid Res; 2000 Nov; 41(11):1801-7. PubMed ID: 11060349
[TBL] [Abstract][Full Text] [Related]
30. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
[TBL] [Abstract][Full Text] [Related]
31. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
32. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
33. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
34. Peroxisomal beta-oxidation of branched chain fatty acids in human skin fibroblasts.
Singh H; Brogan M; Johnson D; Poulos A
J Lipid Res; 1992 Nov; 33(11):1597-605. PubMed ID: 1464743
[TBL] [Abstract][Full Text] [Related]
35. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes.
Pahan K; Singh I
J Lipid Res; 1995 May; 36(5):986-97. PubMed ID: 7544821
[TBL] [Abstract][Full Text] [Related]
36. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
37. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.
Mukherji M; Kershaw NJ; Schofield CJ; Wierzbicki AS; Lloyd MD
Chem Biol; 2002 May; 9(5):597-605. PubMed ID: 12031666
[TBL] [Abstract][Full Text] [Related]
38. Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.
Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Adv Exp Med Biol; 2020; 1299():55-70. PubMed ID: 33417207
[TBL] [Abstract][Full Text] [Related]
39. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
Pahan K; Khan M; Singh I
J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
